B. Riley Has Bearish Estimate for Aspen Aerogels Q3 Earnings

Aspen Aerogels, Inc. (NYSE:ASPNFree Report) – Stock analysts at B. Riley lowered their Q3 2025 earnings per share estimates for shares of Aspen Aerogels in a report released on Wednesday, February 19th. B. Riley analyst R. Pfingst now anticipates that the construction company will earn $0.13 per share for the quarter, down from their previous forecast of $0.16. B. Riley has a “Buy” rating and a $22.00 price objective on the stock. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.46 per share. B. Riley also issued estimates for Aspen Aerogels’ Q4 2025 earnings at $0.15 EPS, FY2026 earnings at $0.75 EPS and FY2027 earnings at $1.30 EPS.

Aspen Aerogels (NYSE:ASPNGet Free Report) last issued its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%.

Several other analysts also recently issued reports on ASPN. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a research note on Wednesday. Roth Mkm decreased their price target on Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a research note on Friday, February 14th. Seaport Res Ptn downgraded Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 12th. Canaccord Genuity Group decreased their price target on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, February 14th. Finally, Barclays decreased their price target on Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating for the company in a research note on Wednesday. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $22.44.

Read Our Latest Stock Analysis on Aspen Aerogels

Aspen Aerogels Stock Performance

Shares of ASPN stock opened at $8.32 on Thursday. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. Aspen Aerogels has a fifty-two week low of $8.25 and a fifty-two week high of $33.15. The stock’s 50-day moving average is $11.85 and its two-hundred day moving average is $18.22. The firm has a market cap of $682.38 million, a P/E ratio of 51.98 and a beta of 2.14.

Institutional Trading of Aspen Aerogels

Hedge funds have recently modified their holdings of the company. Sandia Investment Management LP bought a new stake in shares of Aspen Aerogels in the 4th quarter worth approximately $89,000. AlphaQuest LLC lifted its position in shares of Aspen Aerogels by 54.0% in the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company’s stock worth $135,000 after acquiring an additional 3,998 shares during the period. KLP Kapitalforvaltning AS bought a new stake in shares of Aspen Aerogels in the 4th quarter worth approximately $164,000. Connors Investor Services Inc. bought a new stake in shares of Aspen Aerogels in the 4th quarter worth approximately $168,000. Finally, Journey Strategic Wealth LLC bought a new stake in shares of Aspen Aerogels in the 4th quarter worth approximately $178,000. Institutional investors own 97.64% of the company’s stock.

About Aspen Aerogels

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Articles

Earnings History and Estimates for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.